APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nicotinamide Phosphoribosyltransferase

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Nicotinamide Phosphoribosyltransferase Market Outlook and Growth Opportunities 2026

19 December 2025195 pages

Choose your research edition.

Industry ResearchNicotinamide Phosphoribosyltransferase Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Nicotinamide Phosphoribosyltransferase Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Nicotinamide Phosphoribosyltransferase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nicotinamide Phosphoribosyltransferase Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Nicotinamide Phosphoribosyltransferase Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Nicotinamide Phosphoribosyltransferase market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Nicotinamide Phosphoribosyltransferase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nicotinamide Phosphoribosyltransferase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nicotinamide Phosphoribosyltransferase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Nicotinamide Phosphoribosyltransferase market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Nicotinamide Phosphoribosyltransferase market include OncoTartis, Inc., Karyopharm Therapeutics, Inc., Genentech, Inc., FORMA Therapeutics, Inc., Calico LLC, Aurigene Discovery Technologies Limited and Angelini Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Nicotinamide Phosphoribosyltransferase market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nicotinamide Phosphoribosyltransferase and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nicotinamide Phosphoribosyltransferase sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nicotinamide Phosphoribosyltransferase market size, projected growth trends, production technologies, key applications, and end-use industries.

Nicotinamide Phosphoribosyltransferase Segment by Company

OncoTartis, Inc.

Karyopharm Therapeutics, Inc.

Genentech, Inc.

FORMA Therapeutics, Inc.

Calico LLC

Aurigene Discovery Technologies Limited

Angelini Group

Nicotinamide Phosphoribosyltransferase Segment by Type

Lipids

Small Molecule Compounds

Hormone

Others

Nicotinamide Phosphoribosyltransferase Segment by Application

Breast Cancer

Parkinson's Disease

Acute Lung Injury

Others

Nicotinamide Phosphoribosyltransferase Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Nicotinamide Phosphoribosyltransferase status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Nicotinamide Phosphoribosyltransferase market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Nicotinamide Phosphoribosyltransferase significant trends, drivers, influence factors in global and regions.

6. To analyze Nicotinamide Phosphoribosyltransferase competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nicotinamide Phosphoribosyltransferase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nicotinamide Phosphoribosyltransferase and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nicotinamide Phosphoribosyltransferase.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nicotinamide Phosphoribosyltransferase market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nicotinamide Phosphoribosyltransferase industry.

Chapter 3: Detailed analysis of Nicotinamide Phosphoribosyltransferase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Nicotinamide Phosphoribosyltransferase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Nicotinamide Phosphoribosyltransferase in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Nicotinamide Phosphoribosyltransferase Industry Trends Table 2. Nicotinamide Phosphoribosyltransferase Industry Drivers Table 3. Nicotinamide Phosphoribosyltransferase Industry Opportunities and Challenges Table 4. Nicotinamide Phosphoribosyltransferase Industry Restraints Table 5. Global Nicotinamide Phosphoribosyltransferase Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Nicotinamide Phosphoribosyltransferase Revenue Share by Company (2021-2026) Table 7. Global Nicotinamide Phosphoribosyltransferase Sales Volume by Company (W Tons) & (2021-2026) Table 8. Global Nicotinamide Phosphoribosyltransferase Sales Volume Share by Company (2021-2026) Table 9. Global Nicotinamide Phosphoribosyltransferase Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Nicotinamide Phosphoribosyltransferase Company Ranking, (2024-2026) & (USD Million) Table 11. Global Nicotinamide Phosphoribosyltransferase Key Company Manufacturing Base & Headquarters Table 12. Global Nicotinamide Phosphoribosyltransferase Company, Product Type & Application Table 13. Global Nicotinamide Phosphoribosyltransferase Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Nicotinamide Phosphoribosyltransferase by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Lipids Table 18. Significant Companies of Small Molecule Compounds Table 19. Significant Companies of Hormone Table 20. Significant Companies of Others Table 21. Global Nicotinamide Phosphoribosyltransferase Sales Volume by Type 2021 VS 2025 VS 2032 (W Tons) Table 22. Global Nicotinamide Phosphoribosyltransferase Sales Volume by Type (2021-2026) & (W Tons) Table 23. Global Nicotinamide Phosphoribosyltransferase Sales Volume by Type (2027-2032) & (W Tons) Table 24. Global Nicotinamide Phosphoribosyltransferase Sales Volume Share by Type (2021-2026) Table 25. Global Nicotinamide Phosphoribosyltransferase Sales Volume Share by Type (2027-2032) Table 26. Global Nicotinamide Phosphoribosyltransferase Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Nicotinamide Phosphoribosyltransferase Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Nicotinamide Phosphoribosyltransferase Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Nicotinamide Phosphoribosyltransferase Sales Value Share by Type (2021-2026) Table 30. Global Nicotinamide Phosphoribosyltransferase Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Breast Cancer Table 32. Significant Companies of Parkinson's Disease Table 33. Significant Companies of Acute Lung Injury Table 34. Significant Companies of Others Table 35. Global Nicotinamide Phosphoribosyltransferase Sales Volume by Application 2021 VS 2025 VS 2032 (W Tons) Table 36. Global Nicotinamide Phosphoribosyltransferase Sales Volume by Application (2021-2026) & (W Tons) Table 37. Global Nicotinamide Phosphoribosyltransferase Sales Volume by Application (2027-2032) & (W Tons) Table 38. Global Nicotinamide Phosphoribosyltransferase Sales Volume Share by Application (2021-2026) Table 39. Global Nicotinamide Phosphoribosyltransferase Sales Volume Share by Application (2027-2032) Table 40. Global Nicotinamide Phosphoribosyltransferase Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Nicotinamide Phosphoribosyltransferase Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Nicotinamide Phosphoribosyltransferase Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Nicotinamide Phosphoribosyltransferase Sales Value Share by Application (2021-2026) Table 44. Global Nicotinamide Phosphoribosyltransferase Sales Value Share by Application (2027-2032) Table 45. Global Nicotinamide Phosphoribosyltransferase Sales by Region: 2021 VS 2025 VS 2032 (W Tons) Table 46. Global Nicotinamide Phosphoribosyltransferase Sales by Region (2021-2026) & (W Tons) Table 47. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Region (2021-2026) Table 48. Global Nicotinamide Phosphoribosyltransferase Sales by Region (2027-2032) & (W Tons) Table 49. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Region (2027-2032) Table 50. Global Nicotinamide Phosphoribosyltransferase Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Nicotinamide Phosphoribosyltransferase Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Nicotinamide Phosphoribosyltransferase Sales Value Share by Region (2021-2026) Table 53. Global Nicotinamide Phosphoribosyltransferase Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Nicotinamide Phosphoribosyltransferase Sales Value Share by Region (2027-2032) Table 55. Global Nicotinamide Phosphoribosyltransferase Market Average Price (US$/Ton) by Region (2021-2026) Table 56. Global Nicotinamide Phosphoribosyltransferase Market Average Price (US$/Ton) by Region (2027-2032) Table 57. Global Nicotinamide Phosphoribosyltransferase Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Table 58. Global Nicotinamide Phosphoribosyltransferase Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Nicotinamide Phosphoribosyltransferase Sales by Country (2021-2026) & (W Tons) Table 60. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Country (2021-2026) Table 61. Global Nicotinamide Phosphoribosyltransferase Sales by Country (2027-2032) & (W Tons) Table 62. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Country (2027-2032) Table 63. Global Nicotinamide Phosphoribosyltransferase Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Nicotinamide Phosphoribosyltransferase Sales Value Market Share by Country (2021-2026) Table 65. Global Nicotinamide Phosphoribosyltransferase Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Nicotinamide Phosphoribosyltransferase Sales Value Market Share by Country (2027-2032) Table 67. OncoTartis, Inc. Company Information Table 68. OncoTartis, Inc. Business Overview Table 69. OncoTartis, Inc. Nicotinamide Phosphoribosyltransferase Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 70. OncoTartis, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio Table 71. OncoTartis, Inc. Recent Development Table 72. Karyopharm Therapeutics, Inc. Company Information Table 73. Karyopharm Therapeutics, Inc. Business Overview Table 74. Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 75. Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio Table 76. Karyopharm Therapeutics, Inc. Recent Development Table 77. Genentech, Inc. Company Information Table 78. Genentech, Inc. Business Overview Table 79. Genentech, Inc. Nicotinamide Phosphoribosyltransferase Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 80. Genentech, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio Table 81. Genentech, Inc. Recent Development Table 82. FORMA Therapeutics, Inc. Company Information Table 83. FORMA Therapeutics, Inc. Business Overview Table 84. FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 85. FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio Table 86. FORMA Therapeutics, Inc. Recent Development Table 87. Calico LLC Company Information Table 88. Calico LLC Business Overview Table 89. Calico LLC Nicotinamide Phosphoribosyltransferase Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 90. Calico LLC Nicotinamide Phosphoribosyltransferase Product Portfolio Table 91. Calico LLC Recent Development Table 92. Aurigene Discovery Technologies Limited Company Information Table 93. Aurigene Discovery Technologies Limited Business Overview Table 94. Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 95. Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Product Portfolio Table 96. Aurigene Discovery Technologies Limited Recent Development Table 97. Angelini Group Company Information Table 98. Angelini Group Business Overview Table 99. Angelini Group Nicotinamide Phosphoribosyltransferase Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 100. Angelini Group Nicotinamide Phosphoribosyltransferase Product Portfolio Table 101. Angelini Group Recent Development Table 102. Key Raw Materials Table 103. Raw Materials Key Suppliers Table 104. Nicotinamide Phosphoribosyltransferase Distributors List Table 105. Nicotinamide Phosphoribosyltransferase Customers List Table 106. Research Programs/Design for This Report Table 107. Authors List of This Report Table 108. Secondary Sources Table 109. Primary Sources List of Figures Figure 1. Nicotinamide Phosphoribosyltransferase Product Image Figure 2. Global Nicotinamide Phosphoribosyltransferase Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nicotinamide Phosphoribosyltransferase Sales Value (2021-2032) & (US$ Million) Figure 4. Global Nicotinamide Phosphoribosyltransferase Sales (2021-2032) & (W Tons) Figure 5. Global Nicotinamide Phosphoribosyltransferase Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Nicotinamide Phosphoribosyltransferase Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Lipids Image Figure 10. Small Molecule Compounds Image Figure 11. Hormone Image Figure 12. Others Image Figure 13. Global Nicotinamide Phosphoribosyltransferase Sales Volume by Type (2021 VS 2025 VS 2032) & (W Tons) Figure 14. Global Nicotinamide Phosphoribosyltransferase Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Nicotinamide Phosphoribosyltransferase Sales Volume Share by Type (2021-2032) Figure 16. Global Nicotinamide Phosphoribosyltransferase Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Nicotinamide Phosphoribosyltransferase Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Nicotinamide Phosphoribosyltransferase Sales Value Share by Type (2021-2032) Figure 19. Breast Cancer Image Figure 20. Parkinson's Disease Image Figure 21. Acute Lung Injury Image Figure 22. Others Image Figure 23. Global Nicotinamide Phosphoribosyltransferase Sales Volume by Application (2021 VS 2025 VS 2032) & (W Tons) Figure 24. Global Nicotinamide Phosphoribosyltransferase Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Nicotinamide Phosphoribosyltransferase Sales Volume Share by Application (2021-2032) Figure 26. Global Nicotinamide Phosphoribosyltransferase Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Nicotinamide Phosphoribosyltransferase Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Nicotinamide Phosphoribosyltransferase Sales Value Share by Application (2021-2032) Figure 29. Global Nicotinamide Phosphoribosyltransferase Sales by Region: 2021 VS 2025 VS 2032 (W Tons) Figure 30. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Nicotinamide Phosphoribosyltransferase Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Nicotinamide Phosphoribosyltransferase Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Nicotinamide Phosphoribosyltransferase Sales Value (2021-2032) & (US$ Million) Figure 34. North America Nicotinamide Phosphoribosyltransferase Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Nicotinamide Phosphoribosyltransferase Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Nicotinamide Phosphoribosyltransferase Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Nicotinamide Phosphoribosyltransferase Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Nicotinamide Phosphoribosyltransferase Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Nicotinamide Phosphoribosyltransferase Sales Value (2021-2032) & (US$ Million) Figure 40. South America Nicotinamide Phosphoribosyltransferase Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Nicotinamide Phosphoribosyltransferase Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Nicotinamide Phosphoribosyltransferase Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Nicotinamide Phosphoribosyltransferase Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Nicotinamide Phosphoribosyltransferase Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Lipids
  • Small Molecule Compounds
  • Hormone
  • Others
Applications
  • Breast Cancer
  • Parkinson's Disease
  • Acute Lung Injury
  • Others
Companies covered
  • OncoTartis, Inc.
  • Karyopharm Therapeutics, Inc.
  • Genentech, Inc.
  • FORMA Therapeutics, Inc.
  • Calico LLC
  • Aurigene Discovery Technologies Limited
  • Angelini Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nicotinamide Phosphoribosyltransferase Sales Value (2021-2032)
  4. 1.2.2 Global Nicotinamide Phosphoribosyltransferase Sales Volume (2021-2032)
  5. 1.2.3 Global Nicotinamide Phosphoribosyltransferase Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Nicotinamide Phosphoribosyltransferase Market Dynamics
  1. 2.1 Nicotinamide Phosphoribosyltransferase Industry Trends
  2. 2.2 Nicotinamide Phosphoribosyltransferase Industry Drivers
  3. 2.3 Nicotinamide Phosphoribosyltransferase Industry Opportunities and Challenges
  4. 2.4 Nicotinamide Phosphoribosyltransferase Industry Restraints
3 Nicotinamide Phosphoribosyltransferase Market by Company
  1. 3.1 Global Nicotinamide Phosphoribosyltransferase Company Revenue Ranking in 2025
  2. 3.2 Global Nicotinamide Phosphoribosyltransferase Revenue by Company (2021-2026)
  3. 3.3 Global Nicotinamide Phosphoribosyltransferase Sales Volume by Company (2021-2026)
  4. 3.4 Global Nicotinamide Phosphoribosyltransferase Average Price by Company (2021-2026)
  5. 3.5 Global Nicotinamide Phosphoribosyltransferase Company Ranking (2024-2026)
  6. 3.6 Global Nicotinamide Phosphoribosyltransferase Company Manufacturing Base and Headquarters
  7. 3.7 Global Nicotinamide Phosphoribosyltransferase Company Product Type and Application
  8. 3.8 Global Nicotinamide Phosphoribosyltransferase Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Nicotinamide Phosphoribosyltransferase Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Nicotinamide Phosphoribosyltransferase Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Nicotinamide Phosphoribosyltransferase Market by Type
  1. 4.1 Nicotinamide Phosphoribosyltransferase Type Introduction
  2. 4.1.1 Lipids
  3. 4.1.2 Small Molecule Compounds
  4. 4.1.3 Hormone
  5. 4.1.4 Others
  6. 4.2 Global Nicotinamide Phosphoribosyltransferase Sales Volume by Type
  7. 4.2.1 Global Nicotinamide Phosphoribosyltransferase Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Nicotinamide Phosphoribosyltransferase Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Nicotinamide Phosphoribosyltransferase Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Nicotinamide Phosphoribosyltransferase Sales Value by Type
  11. 4.3.1 Global Nicotinamide Phosphoribosyltransferase Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Nicotinamide Phosphoribosyltransferase Sales Value by Type (2021-2032)
  13. 4.3.3 Global Nicotinamide Phosphoribosyltransferase Sales Value Share by Type (2021-2032)
5 Nicotinamide Phosphoribosyltransferase Market by Application
  1. 5.1 Nicotinamide Phosphoribosyltransferase Application Introduction
  2. 5.1.1 Breast Cancer
  3. 5.1.2 Parkinson's Disease
  4. 5.1.3 Acute Lung Injury
  5. 5.1.4 Others
  6. 5.2 Global Nicotinamide Phosphoribosyltransferase Sales Volume by Application
  7. 5.2.1 Global Nicotinamide Phosphoribosyltransferase Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Nicotinamide Phosphoribosyltransferase Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Nicotinamide Phosphoribosyltransferase Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Nicotinamide Phosphoribosyltransferase Sales Value by Application
  11. 5.3.1 Global Nicotinamide Phosphoribosyltransferase Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Nicotinamide Phosphoribosyltransferase Sales Value by Application (2021-2032)
  13. 5.3.3 Global Nicotinamide Phosphoribosyltransferase Sales Value Share by Application (2021-2032)
6 Nicotinamide Phosphoribosyltransferase Regional Sales and Value Analysis
  1. 6.1 Global Nicotinamide Phosphoribosyltransferase Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nicotinamide Phosphoribosyltransferase Sales by Region (2021-2032)
  3. 6.2.1 Global Nicotinamide Phosphoribosyltransferase Sales by Region: 2021-2026
  4. 6.2.2 Global Nicotinamide Phosphoribosyltransferase Sales by Region (2027-2032)
  5. 6.3 Global Nicotinamide Phosphoribosyltransferase Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Nicotinamide Phosphoribosyltransferase Sales Value by Region (2021-2032)
  7. 6.4.1 Global Nicotinamide Phosphoribosyltransferase Sales Value by Region: 2021-2026
  8. 6.4.2 Global Nicotinamide Phosphoribosyltransferase Sales Value by Region (2027-2032)
  9. 6.5 Global Nicotinamide Phosphoribosyltransferase Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Nicotinamide Phosphoribosyltransferase Sales Value (2021-2032)
  12. 6.6.2 North America Nicotinamide Phosphoribosyltransferase Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Nicotinamide Phosphoribosyltransferase Sales Value (2021-2032)
  15. 6.7.2 Europe Nicotinamide Phosphoribosyltransferase Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Nicotinamide Phosphoribosyltransferase Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Nicotinamide Phosphoribosyltransferase Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Nicotinamide Phosphoribosyltransferase Sales Value (2021-2032)
  21. 6.9.2 South America Nicotinamide Phosphoribosyltransferase Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Nicotinamide Phosphoribosyltransferase Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Nicotinamide Phosphoribosyltransferase Sales Value Share by Country, 2025 VS 2032
7 Nicotinamide Phosphoribosyltransferase Country-level Sales and Value Analysis
  1. 7.1 Global Nicotinamide Phosphoribosyltransferase Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Nicotinamide Phosphoribosyltransferase Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Nicotinamide Phosphoribosyltransferase Sales by Country (2021-2032)
  4. 7.3.1 Global Nicotinamide Phosphoribosyltransferase Sales by Country (2021-2026)
  5. 7.3.2 Global Nicotinamide Phosphoribosyltransferase Sales by Country (2027-2032)
  6. 7.4 Global Nicotinamide Phosphoribosyltransferase Sales Value by Country (2021-2032)
  7. 7.4.1 Global Nicotinamide Phosphoribosyltransferase Sales Value by Country (2021-2026)
  8. 7.4.2 Global Nicotinamide Phosphoribosyltransferase Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Nicotinamide Phosphoribosyltransferase Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Nicotinamide Phosphoribosyltransferase Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Nicotinamide Phosphoribosyltransferase Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 OncoTartis, Inc.
  2. 8.1.1 OncoTartis, Inc. Company Information
  3. 8.1.2 OncoTartis, Inc. Business Overview
  4. 8.1.3 OncoTartis, Inc. Nicotinamide Phosphoribosyltransferase Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 OncoTartis, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio
  6. 8.1.5 OncoTartis, Inc. Recent Developments
  7. 8.2 Karyopharm Therapeutics, Inc.
  8. 8.2.1 Karyopharm Therapeutics, Inc. Company Information
  9. 8.2.2 Karyopharm Therapeutics, Inc. Business Overview
  10. 8.2.3 Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio
  12. 8.2.5 Karyopharm Therapeutics, Inc. Recent Developments
  13. 8.3 Genentech, Inc.
  14. 8.3.1 Genentech, Inc. Company Information
  15. 8.3.2 Genentech, Inc. Business Overview
  16. 8.3.3 Genentech, Inc. Nicotinamide Phosphoribosyltransferase Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Genentech, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio
  18. 8.3.5 Genentech, Inc. Recent Developments
  19. 8.4 FORMA Therapeutics, Inc.
  20. 8.4.1 FORMA Therapeutics, Inc. Company Information
  21. 8.4.2 FORMA Therapeutics, Inc. Business Overview
  22. 8.4.3 FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio
  24. 8.4.5 FORMA Therapeutics, Inc. Recent Developments
  25. 8.5 Calico LLC
  26. 8.5.1 Calico LLC Company Information
  27. 8.5.2 Calico LLC Business Overview
  28. 8.5.3 Calico LLC Nicotinamide Phosphoribosyltransferase Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Calico LLC Nicotinamide Phosphoribosyltransferase Product Portfolio
  30. 8.5.5 Calico LLC Recent Developments
  31. 8.6 Aurigene Discovery Technologies Limited
  32. 8.6.1 Aurigene Discovery Technologies Limited Company Information
  33. 8.6.2 Aurigene Discovery Technologies Limited Business Overview
  34. 8.6.3 Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Product Portfolio
  36. 8.6.5 Aurigene Discovery Technologies Limited Recent Developments
  37. 8.7 Angelini Group
  38. 8.7.1 Angelini Group Company Information
  39. 8.7.2 Angelini Group Business Overview
  40. 8.7.3 Angelini Group Nicotinamide Phosphoribosyltransferase Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Angelini Group Nicotinamide Phosphoribosyltransferase Product Portfolio
  42. 8.7.5 Angelini Group Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Nicotinamide Phosphoribosyltransferase Value Chain Analysis
  2. 9.1.1 Nicotinamide Phosphoribosyltransferase Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Nicotinamide Phosphoribosyltransferase Sales Mode & Process
  6. 9.2 Nicotinamide Phosphoribosyltransferase Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Nicotinamide Phosphoribosyltransferase Distributors
  9. 9.2.3 Nicotinamide Phosphoribosyltransferase Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst